UNSPSC 85813912: Introduction of oxazolidinones into muscle, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of oxazolidinones into muscle, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E02328

UNSPSC 85813912, a Commodity code for injection of oxazolidinones into muscle via percutaneous approach, shows no relevant recent state and local procurement activity. The code describes a narrow clinical procedure, but the 40 opportunities posted between July and October 2026 span behavioral health services, occupational health programs, wellness platforms, emergency medical services, cancer screening, crisis stabilization, opioid treatment, nursing home operations, telehealth, and specialty medical staffing—none of which align with intramuscular oxazolidinone injection services. The mismatch suggests either an indexing error in the state and local opportunity database or dormant procurement volume under this code.

State and local health systems, counties, and specialized providers are actively buying medical and behavioral health services across the public sector right now, but they are not currently soliciting for oxazolidinone injection delivery or related procedural services at the scale or frequency captured in recent RFP, RFQ, and ITB activity. If your firm serves this clinical niche, the immediate opportunity set under this code is not supported by recent procurement signals.